Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 60
Population
60 volunteers aged 30 to 60 years who were diagnosed with MetSyn in Shiraz, Iran
Methods
Randomized controlled interventional trial; block randomization to SO (25 mL/d SO) and FO (25 mL/d FO) groups; identical diets; measurements at baseline and end of week 7
Duration
7 weeks
Funding
Unclear

Background

Metabolic syndrome (MetSyn) increases the risk of type II diabetes and morbidity and mortality due to cardiovascular diseases. Flaxseed oil (FO), as a functional food, is one of the major vegetal sources of essential omega-3 fatty acids.

Objective

This study aimed to compare the effects of consumption of FO and sunflower seed oil (SO) on lipid peroxidation and other symptoms of MetSyn.

Methods

This randomized controlled interventional trial was conducted on 60 volunteers aged 30 to 60 years who were diagnosed with MetSyn in Shiraz, Iran. The participants who fulfilled the inclusion criteria were randomly assigned to SO (n = 30, receiving 25 mL/d SO) and FO (n = 30, receiving 25 ml/d FO) groups using block randomization. The diets were identical for all the participants. Blood pressure (BP), serum lipid, fasting blood sugar, and malondialdehyde were measured at baseline and at the end of week 7.

Result

The results showed no significant difference between the 2 groups regarding blood lipid levels and fasting blood sugar at the end of the study. However, significant reductions in total cholesterol, low-density lipoprotein cholesterol (5.6% in FO and 10.8% in SO), and triglyceride levels were seen within each group after treatment with FO and SO (P < .05). Nonetheless, between-group changes were significant (<0.05) for systolic BP (mean [±standard deviation {SD}] changes were -14.0 ± 22.41 in the FO group [P = .004] and 0.92 ± 8.70 in the SO group [P = .594]) and diastolic BP (mean [±SD] changes were -4.26 ± 7.44 in the FO group [P = .007] and 1.30 ± 6.91 in the SO group [P = .344]), but marginally significant (P = .053) for malondialdehyde level (mean [±SD] changes were -1.29 ± 1.48 in the FO group [P < .001] and -0.52 ± 1.34 in the SO group [P = .52]). A significant decrease in weight was also found in both groups. However, waist circumference decreased significantly only in the FO group at the end of the study (P < .05).

Conclusion

Our results indicated that dietary FO could be effective in amelioration of some symptoms of MetSyn and decrease BP and lipid peroxidation.

Research Insights

  • significant reductions in total cholesterol... were seen within each group after treatment with FO and SO (P < .05)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    25 mL/day
  • A significant decrease in weight was also found in both groups.

    Effect
    Beneficial
    Effect size
    Small
    Dose
    25 mL/day
  • between-group changes were significant (<0.05) for... diastolic BP (mean [±SD] changes were -4.26 ± 7.44 in the FO group [P = .007] and 1.30 ± 6.91 in the SO group [P = .344])

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    25 mL/day
  • The results showed no significant difference between the 2 groups regarding blood lipid levels and fasting blood sugar at the end of the study.

    Effect
    Neutral
    Effect size
    Small
    Dose
    25 mL/day
  • significant reductions in... low-density lipoprotein cholesterol (5.6% in FO and 10.8% in SO)... were seen within each group after treatment with FO and SO (P < .05)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    25 mL/day
  • marginally significant (P = .053) for malondialdehyde level (mean [±SD] changes were -1.29 ± 1.48 in the FO group [P < .001] and -0.52 ± 1.34 in the SO group [P = .52])

    Effect
    Neutral
    Effect size
    Small
    Dose
    25 mL/day
  • between-group changes were significant (<0.05) for systolic BP (mean [±standard deviation {SD}] changes were -14.0 ± 22.41 in the FO group [P = .004] and 0.92 ± 8.70 in the SO group [P = .594])

    Effect
    Beneficial
    Effect size
    Large
    Dose
    25 mL/day
  • significant reductions in... triglyceride levels were seen within each group after treatment with FO and SO (P < .05)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    25 mL/day
  • waist circumference decreased significantly only in the FO group at the end of the study (P < .05)

    Effect
    Beneficial
    Effect size
    Small
    Dose
    25 mL/day
Back to top